Table 2 Comorbidities and nutritional status in the overall patients and by gender
Variable | All patients | Men | Women |
|---|---|---|---|
(n = 97) | (n = 49) | (n = 48) | |
Hypertension n (%) | 59 (62.1) | 25 (51) | 34 (70.8)* |
Heart disease (any*) n (%) | 64 (67.4) | 29 (59.2) | 35 (72.9) |
• Hypertensive n (%) | 26 (27.4) | 13 (26.5) | 13 (27.1) |
• Ischemic n (%) | 19 (20.0) | 12 (24.5) | 7 (14.6) |
• Heart failure n (%) | 48 (50.5) | 24 (49.0) | 24 (50.0) |
• Valvular n (%) | 33 (34.7) | 12 (24.5) | 21 (43.8)* |
• Atrial fibrillation n (%) | 22 (23.2) | 12 (24.5) | 10 (20.8) |
Pulmonary hypertension n (%) | 23 (24.2) | 10 (20.4) | 13 (27.1) |
Dyslipidemia n (%) | 33 (34.7) | 15 (30.6) | 18 (37.5) |
Thyroid disease n (%) | 20 (20.6) | 5 (10.2) | 15 (31.3)* |
Diabetes n (%) | 15 (15.8) | 8 (16.3) | 7 (14.6) |
Cerebrovascular disease n (%) | 11 (11.3) | 8 (16.3) | 3 (6.3) |
Renal failure n (%) | 17 (20.2) | 10 (20.4) | 7 (14.6) |
Osteoporosis n (%) | 23 (25.8) | 8 (16.3) | 15 (31.3) |
Cancer n (%) | 17 (17.7) | 11 (22.9) | 6 (12.5) |
Depression/anxiety n (%) | 28 (29.5) | 11 (22.4) | 17 (35.4) |
GERD n (%) | 15 (16.7) | 5 (10.2) | 10 (20.8) |
Obstructive sleep apnea n (%) | 11 (12.4) | 5 (10.2) | 6 (12.5) |
Nutrition parameters | |||
Vitamin D levels (ng/ml) (GM (95%CI)] | 12.0 (10.6 - 13.5) | 15.5 (12.7-18.4) | 12.7 (10.9-14.6) |
Mild-moderate deficiency n (%) | 58 (57.9%) | 31 (63.3) | 27 (56.3) |
Severe deficiency n (%) | 35 (36.1%) | 14 (28.6) | 21 (43.8)* |
Ferritin deficiency (<25 mg/dl) n (%)# | 10 (11.1%) | 4 (8.5) | 6 (14.0) |
Vitamin B12 deficiency (<200 pg/ml) n (%)# | 19 (20.2%) | 11 (22.9) | 8 (17.4) |
Folic acid deficiency (<4.5 ng7ml) n (%)# | 33 (35.9%) | 16 (34.0) | 17 (37.8) |